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Synopsis : Squamous Cell Carcinoma can rarely occur in the conjunctiva of 
anophthalmic sockets. The exact cause is unclear, but it is likely that human 
papillomavirus may play a role. 
 
All authors contributed to the design and implantation of this research, to the 
analysis of the results and writing of the manuscript.  
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ABSTRACT 
 
Purpose : To present the clinical and histological features of squamous cell 
carcinoma (SCC) in the anophthalmic socket in 4 adult patients, and to determine the 
presence of human papillomavirus infection (HPV).  
  
Methods : Retrospective case series of 4 adult patients with SCC of the anophthalmic 
socket. P16 immunohistochemistry and HPV testing was carried out in all cases. The 
authors report clinical findings, histopathology, management and outcomes for all 4 
patients with conjunctival SCC. Previously reported cases of conjunctival SCC in 
anophthalmic sockets were reviewed. 
 
Results : Four adult patients presented with eyelid lumps, discharge or change in 
prosthesis fit. Common examination findings included papillomatous changes, eyelid 
masses and epithelial changes. Three out of the four cases (75%) were positive for 
p16 by immunohistochemistry and the same cases positive for HPV-16 DNA. All 
patients received cryotherapy, topical or intralesional chemotherapy. Two patients 
proceeded to exenteration for control of invasive disease. 
 
Conclusions : To the authors’ knowledge, this is the largest series of SCC in the 
anophthalmic socket with comprehensive annotation of HPV status. Although socket 
conjunctiva is protected from environmental radiation, there is still a risk of 
neoplastic transformation in this tissue, thus patient education and regular checking 
of sockets by ophthalmologists should be undertaken as a preventative measure. 
The potential role of HPV in these tumours warrants further investigation. 
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Introduction  
Squamous cell carcinoma (SCC) of the conjunctiva is an uncommon condition, with a 
worldwide incidence ranging from 0.02 to 3.5 per 100000.1 It typically presents in 
sun exposed ocular surface, at the limbus, in elderly Caucasian men.2 Typical 
presenting features include a gelatinous, velvety or papilliform growth with 
leukoplakic, nodular or diffuse growth at the limbus and a complaint of irritation or 
redness of the eye.2 Known predisposing factors include cigarette exposure, 
radiation exposure, eczema / atopy, systemic immune suppression, human 
immunodeficiency virus infection and xeroderma pigmentosum.1 
 
Conjunctival SCC arising in the anophthalmic socket has been reported in 16 cases in 
the English language literature since 1998. The majority have been presumed to be 
related to chronic prosthesis use and related irritation, given that actinic exposure is 
minimal or absent in these tissues due to prosthesis wear. However a recent report 
by Gaier and coworkers reported HPV-16 positivity in one case, and postulated an 
association with this virus.3  
 
Human papillomavirus is a small epitheliotropic, non-enveloped DNA virus with more 
than 200 genotypes identified, of which around 13 “high risk” types are associated 
with certain anogenital cancers and a component of oropharyngeal cancer.4 The 
steps in HPV-driven carginogenesis include infection, persistence of infection, 
progression to premalignant lesions and invasion.5 In the absence of invasive 
disease, precursor lesions can be reversible.  The most carcinogenic type is HPV-16 
which is an order of magnitude more oncogenic than any other high risk type. While 
most infection follows a subclinical or benign trajectory; the non lytic nature of the 
virus and the comparative lack of immunological effector cells in the epithelium 
enables some infections to persist, which can subsequently render a malignant 
phenotype through the deregulated expression key oncoproteins E6 and E7.6 While 
the nature and characteristics of a latent period for HPV infection is less well 
understood compared to other viruses, there is evidence that HPV can persist in 
basal cells for several years before reactivation as a consequence of external 
(uncharacterised) stimuli.7  
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Most conjunctival papillomas are associated with HPV 6 and 11 – low risk types, 
although reports of high risk HPV in conjunctival papillomas, dysplasias and cancers 
also exist. The role of high risk HPV in conjunctival squamous carcinoma remains 
unclear and this is consistent with outputs from the International Agency for 
Research on Cancer which indicate the evidence for a role of HPV is limited.8 There is 
significant evidence, however, for the increasing burden of HPV associated cancer in 
the United Kingdom (UK) and national registry data indicate a rise in vulval, anal, 
penile and vaginal cancer, all of which have an HPV component.5  
 
An awareness of risk factors can lead to increased screening and early detection in 
populations at risk for a disease. In addition, earlier aggressive treatment of low 
grade tumours may help reduce the progression to invasive disease and burden of 
cancer in those with high risk features. Furthermore the increasing burden of HPV-
driven head and neck cancer justify an assessment of HPV status for this rare but 
morbid group of tumours. The aim of this study was to characterise a consecutive 
series of four patients presenting with conjunctival squamous cell carcinoma in the 
anophthalmic socket with respect to clinical, histological and virological features. 
 
Methods 
A review of the records from the Wolverhampton Eye Infirmary and the Ocular 
Oncology Service at the Royal Hallamshire Hospital for the diagnosis of conjunctival 
SCC was performed. Patients wearing a cosmetic prosthesis overlying the socket, 
presenting from 2012-2017 were included in this retrospective case series. The notes 
were reviewed for demographic features, medical history, presenting symptoms; 
surgical procedures, local treatments, and the response to treatment during follow 
up. The patient photography database was also reviewed. The patients gave routine 
consent to have the biopsies and further surgery performed. The work was done in 
accordance with the Declaration of Helsinki. 
 
All surgically removed tissues were fixed in standard buffered formalin for up to 24 
hours, processed to wax and 4 micron sections cut and stained with Haematoxylin 
and Eosin (H&E). All cases were tested with p16 immunohistochemistry staining with 
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p16 ready to use antibody (Roche, Brighton UK). Antigen retrieval was carried out 
using the Dako low pH target retrieval solution. The primary incubation was for 20 
minutes, followed by a 20 minute horse radish peroxidase step, followed by a DAB 5 
minute step (with a brown end point). The immunohistochemistry was carried out in 
the Dako OMNIS system. Nucleic acid extraction of 10 um sections of the  relevant 
FFPE block was performed using the reagents within the DNA mini kit (Qiagen, 
Hilden, Germany) with a protocol adapted to maximise HPV nucleic acid recovery.9 
DNA extracts were then tested for HPV using the Optiplex HPV Genotyping Kit 
(Diamex GmbH, Heidelberg, Germany) according to manufacturer’s instructions. This 
genotyping test detect 24 HPV types including all established high-risk types and is 
the assay used for national HPV surveillance in Scotland to determine impact of the 
HPV vaccine.4 
 
 
Case Series 
CASE 1  
A 59-year-old man was involved in a motor vehicle accident 30 years prior to 
presentation, causing a ruptured right globe and subsequent enucleation. He had 
since worn multiple prostheses, and had no specific problems with fit. He presented 
with a 2-year history of a lump on the right upper eyelid. There was no discharge. 
Examination revealed right upper eyelid swelling with a firm central mass and 
downward displacement of the prosthesis. Ulceration and abnormal vasculature 
were noted on lid eversion (Figure 1a-b). The patient was a smoker of 15 cigarettes 
per day, and took medication for high blood pressure and cholesterol. His work 
history did not reveal exposure to significant ultraviolet radiation or chemicals.  
 
Conjunctival map biopsies revealed in-situ squamous cell carcinoma of the superior 
tarsus. He had further biopsies 2 months later, which showed invasive squamous 
carcinoma. The disease was not controlled with cryotherapy, and he proceeded to 
right orbital exenteration, 3 months post presentation. Histology revealed upper lid 
invasive, moderately differentiated squamous cell carcinoma (Fig 2A and 2B). The 
invasive carcinoma was seen to arise from extensive in-situ carcinoma within the 
7 
 
upper tarsal conjunctiva (Fig 2C). The invasive and in-situ components expressed p16 
within the nuclei and cytoplasm (Fig 2D) and HPV genotyping demonstrated the 
presence of HPV 16 DNA.  
 
CASE 2  
A 65 year-old female had a history of right enucleation, 63 years earlier, for 
treatment of retinoblastoma. She had multiple prostheses since that time, but most 
recently had a new prosthesis 3 months prior to presentation. She was referred from 
a nearby hospital with a new lump in her lower fornix and mucoid discharge from 
her socket. Examination revealed mild erythema of the medial upper and lower 
eyelids, with abnormal conjunctival vasculature noted on lower lid eversion (Figure 
1c-d). 
 
The patient had a history of treated breast carcinoma, osteoarthritis and granuloma 
annulare. She was a non-smoker and had no significant ultraviolet or chemical 
exposure. 
 
The patient had a conjunctival biopsy prior to referral, which showed severely 
dysplastic squamous epithelium, with no underlying stromal tissue. The absence of 
the latter prevented the assessment for the presence or absence of invasive tumour. 
HPV genotying and p16 status was negative. She was treated with cryotherapy and 
subconjunctival interferon alpha-2a. Repeat biopsies, three months post treatment 
showed no residual dysplasia.  
 
CASE 3  
A 63 year-old male had a left enucleation at the age of 21 for management of severe 
globe injury. He had lid surgery for better prosthesis fit 10 years prior to 
presentation. At presentation, he reported 6 months of a lump in the socket, and 
gradual prosthesis migration nasally. He had no significant past medical history and 
was a nonsmoker with no significant occupational chemical or ultraviolet exposure. 
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Examination revealed left ptosis, with a palpable mass of the upper eyelid. Lid 
eversion revealed papillary changes and abnormal vasculature. He was booked for 
map biopsies at presentation, which revealed papillary in-situ SCC. He was treated 
with intralesional interferon and cryotherapy. After cessation of therapy, he had 
rapid growth of the socket lesion, and proceeded to left orbital exenteration. 
Histology revealed an invasive moderate to poorly differentiated squamous cell 
carcinoma of the superior bulbar conjunctiva arising from papillary in-situ SCC (Fig 
1e-f). The tumour was positive for p16 (Fig 2G) and HPV 16 DNA. 
 
CASE 4  
A 73-year-old female had an injury to her right eye at the age of 19. The eye was 
salvaged, but she had an enucleation 10 years prior to presentation for a blind, 
painful eye. She was referred with a 6 month history of a right upper eyelid lump. 
 
This patient was a non-smoker, but suffered severe eczema, and took medication for 
treatment of hypertension, osteoarthritis and asthma. She did not have a history of 
significant environmental chemical or ultraviolet exposure. 
 
On presentation, examination revealed a mass of the medial upper eyelid, with 
leukoplakia and papillomatous changes on lid eversion (Figure 1g-h). She had a 
biopsy at the referring hospital, which revealed papillary in-situ SCC with a 
prominent population of eosinophils (Fig 2H), reflecting the patient’s atopic state. 
The patient proceeded to intralesional interferon on the day of presentation at our 
unit. She had a further wedge excision of the affected eyelid, which revealed 
extensive in-situ squamous cell carcinoma. The tumour was positive for p16 and HPV 
16 DNA. She was successfully treated with three cycles of topical mitomycin C 0.04%.  
 
The key case  findings including HPV/p16 status are summarised in Table 1 
 
Discussion 
There have been 16 cases of conjunctival SCC reported in anophthalmic sockets in 
the literature to date (Table 2). The current study brings the total number of 
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reported cases to 20. The mean age at presentation was 58 years, with a mean of 42 
years of prosthesis wear. The disease is seen to occur more commonly in males (17 
out of 20). The most common presenting features are a mass in the socket (50%), 
poor prosthesis fit (40%) and mucoid discharge (25%). Ten of the 20 reported cases 
(50%) arose in the tarsal or forniceal conjunctiva of the upper eyelid. The majority of 
reported cases (55%) were treated with exenteration, although a recent study by 
Shields and coworkers reported a series of 3 patients all successfully treated with 
topical and intralesional interferon alpha-2b.1  
 
Squamous cell carcinoma of the palpebral conjunctiva and the adjacent lower eyelid 
skin presents a unique dilemma in the determination of a common aetiology. This is 
particularly true in the context of a prosthesis offering protection from ultraviolet 
exposure and other environmental irritants. Traditional hypotheses have related to 
the chronic friction caused by decades of prosthesis wear, leading to conjunctival 
leukoplakia and intraepithelial neoplasia.10 Frictional keratosis and leukoplakia 
associated with underlying squamous cell malignant change is well described in the 
oral mucosa.11 In oral cancer, the role of chronic trauma of the oral mucosa 
contributing to carcinogenesis has been shown to be multifactorial: increased 
mitosis to repair tissue injury put cells at risk of DNA damage by other agents, 
initiating carcinogenesis, release of chemical mediators and / or oxidative stress, 
inhibiting DNA repair, altering transcription factors, preventing apoptosis and 
stimulating angiogenesis.11  
 
There is evidence for a similar mechanism of chronic trauma being relevant to the 
development of conjunctival tumours.10 Physical and inflammatory irritation of the 
conjunctival basement membrane stimulating the oncogenic potential of overlying 
epithelial cells has been proposed as an aetiological factor in SCC development in the 
presence of mucous membrane pemphigoid.12 Poorly fitting prostheses inducing 
conjunctival inflammation and epithelial dysplasia with eventual transformation into 
carcinoma is a favoured cause for the development of conjunctival SCC in 
anophthalmic sockets.10,13-15 
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The hypothesis of friction from a poorly fitting prosthesis leading to the 
development of conjunctival SCC can be addressed by a recent histological study of 
conjunctiva in anopthalmic sockets. Kim and colleagues designed a study to 
determine if a correlation existed between particular aspects of ocular prosthesis 
care, including total wearing time and frequency of polishing, and cytologic features 
of the conjunctival epithelium in impression cytology.16 They found squamous 
metaplasia with decreased goblet cell density and increased nucleus-to-cytoplasm 
ratio occurred in the conjunctiva of anophthalmic sockets, however this was not 
associated with particular aspects of prosthesis care.16 Squamous metaplasia, 
however, is well documented to precede the development of dysplasia in other 
mucosal carcinomas. The upper tarsal or forniceal conjunctiva was seen to be 
involved in 50% of reported cases of SCC in anophthalmic sockets. This is in contrast 
to the majority of conjunctival SCCs which are known to occur most frequently at the 
limbus or bulbar conjunctiva.  The upper eyelid makes the largest excursion over the 
prosthesis in an anophthalmic socket, rendering the tissue lining most susceptible to 
inflammatory change, metaplasia and microtrauma.  
 
High-risk human papilloma virus is a well-established causative agent of a 
component of oropharyngeal carcinomas and cancers of the anogenital tract 
including cervical cancer.5 The association of HPV-16 and carcinomatous 
transformation was extended to the conjunctiva in 1989 when McDonnell and 
coworkers identified the virus in all patients investigated with conjunctival SCC.17 
There has been a marked variation in detection rates of HPV in periocular SCC and 
precursors since that time, ranging from 0 to 100%.18 This variation is likely due to 
differing techniques to identify HPV in biological specimens and differing study 
designs. In 2016 Afrogeh and coauthors were the first to examine the incidence of 
HPV in ocular surface squamous neoplasia using an accepted standardised 
combination of p16 and in-situ hybridisation.18 Using these methods they found HPV-
16 in 30% of conjunctival squamous neoplasia.18 
 
In order to determine whether HPV is a common ‘passenger’ on the ocular surface, 
Sjö and coworkers compared conjunctival papillomas and normal conjunctival 
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tissue.19 They found a strong association between HPV and conjunctival papilloma, 
with types 6 and 11 to be the most frequently detected. In addition, they found all 
normal conjunctival biopsy specimens to be negative for HPV.19  
 
The current study found 3 of 4 patients (75%) were positive for HPV-16 using a very 
sensitive PCR based assay and all three cases were also positive for p16. p16 is the 
product of the INK-4 gene and is a cellular cyclin dependent kinase inhibitor which 
under normal circumstances exerts a tumour suppressor role. Accumulation of p16 
can be triggered by over expression of the E7 oncoproten of high risk HPV and p16 is 
sometimes referred to as a secondary marker of HPV infection as a consequence.20 
Given the ubiquity of HPV infection and sensitivity of PCR based testing, it is possible 
that HPV DNA can be detected in a malignant lesion, yet not be driving it or be 
present as an external contaminant. Furthermore, it is possible for p16 to be 
upregulated in the absence of HPV infection (eg. in some cases of metaplasia). Thus, 
for comprehensive annotation of HPV status of a lesion both p16 and HPV molecular 
testing should be performed, as a double-positive result confers more robust 
evidence that HPV has an active role in the lesion.   
 
A review of the pathophysiology of ocular surface squamous neoplasia was recently 
published which detailed the mechanism of solar ultraviolet radiation, human 
immunodeficiency virus (HIV) and HPV in the transformation of limbal stem cells and 
the development of the disease.21 The presence of HPV-16 in both benign and 
malignant conjunctival lesions has been reported – suggesting that the virus alone is 
incapable of initiating squamous cell carcinoma, but may be a cofactor.22 Gichuhi 
and colleagues identified micro-abrasions of the ocular surface caused by Vitamin A 
deficiency as a risk factor in conjunctival SCC, allowing HPV to invade the 
conjunctival basement membrane and epithelial cells.21 We propose that similar 
microabrasions could be caused by long-term prosthesis wear.  
 
Detecting SCC in the socket is significantly more challenging as the colour contrast of 
the white scleral background is absent, and the vascular tumour blends with the pink 
colour of the socket.3 Tumours are further camouflaged in the fornix. Typically, SCC 
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and its precursors show an array of hairpin loops within the mass.3 Despite these 
pitfalls for the clinician, a thorough examination of all anophthalmic patients, or 
those wearing prostheses should be carried out annually for early detection of 
abnormalities. Patients should be warned to present if they have new masses, 
discharge or altered prosthesis centration. 
 
In conclusion, although exceedingly rare, SCC can develop in the anophthalmic 
socket. It typically presents in males in the fifth decade, with 40-45 years of 
prosthesis wear. Characteristic presenting complaints include a mass or altered 
prosthesis fit. In 3 of the 4 cases HPV-16 was detected which was consistent with the 
p16 result indicating oncogenic activity of HPV within these lesions.  Further 
interrogation of larger national series of SCC in anophthalmic socket may indicate 
whether HPV is playing an increasing role in these cancers as has been observed for 
other neoplasms in the UK. 
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Table 1 : Key Histopathology Findings and HPV status 
 
 
 
 
 
 
 
 
 
 
 
Case number Main 
histopathology 
findings 
p16 
immunohistochemical 
status  
Human 
papillomavirus 16 
status 
1 a.Mapping biopsies: 
extensive in-situ SCC on 
mapping biopsies. 
b.Further biopsy from 
superior tarsus-invasive SCC 
c. Exenteration: Invasive 
SCC and in situ SCC.  
Positive  positive 
2 a.Index biopsy: Granulation 
tissue covered partly with 
in-situ SCC with foci 
suspicious for invasion 
b.Post treatment 
biopsies:No dysplasia  
negative negative 
3 a.Index biopsy: 
Papillomatous in situ SCC 
b.Exenteration: invasive 
SCC with comedo necrosis, 
arising from papillary in-situ 
SCC.  
 
positive positive 
4 a.Index biopsy In-situ SCC 
with numerous eosinophils 
positive positive  
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Table 2 : Previous reports of SCC in Anophthalmic Sockets in the Literature 
 
Author (year) No. of 
Cases 
Age / 
Sex 
Prosthesis 
Use (yrs) 
Presenting 
Features 
Treatment Location Follow Up 
(months) 
Campanella 
(1998)13 
2 69 / M 49 Serosanguineous 
discharge, 
discomfort, mass 
Exenteration Superior Tarsal 
Conjunctiva 
- 
  77 / M 43 Discomfort, 
swelling 
Exenteration Superior Fornix - 
Whittaker 
(2002)10 
1 62 / M 49 Mass, yellow 
discharge 
Excisional 
Biopsy 
Lower Lid and 
Tarsal 
Conjunctiva 
7 
Endo (2006)14 1 51 / M 40 Poor prosthesis fit Exenteration Lower 
conjunctiva 
15 
Chaudhry 
(2006)23 
1 50 / M 50 Irritation Excisional 
Biopsy 
Socket 36  
Nguyen 
(2008)15 
2 58 / M 51 Poor prosthesis fit, 
sanguinous 
discharge 
Exenteration Upper Bulbar 
Conjunctiva 
12  
  56 / M 44 Poor prosthesis fit Exenteration Bulbar 
conjunctiva 
24  
Hsu (2009)24 1 75 / M 63 Mass Exenteration 
and XRT 
Socket 24 
Jain (2010)25 1 60 / M 53 Swelling, poor 
prosthesis 
retention 
Exenteration Upper bulbar and 
palpebral 
Cojunctiva 
- 
Barrett 
(2010)26 
1 58 / M 32 Mucous discharge, 
poor prosthesis fit 
Topical MMC Superior Fornix 10  
Espana 
(2011)27 
1 62 / M 60 Mass Excisional 
Biopsy, MMC, 
Cryo, 
Exenteration 
Superior Fornix 1 
Shields 
(2011)1 
3 60 / F 54 Nodule Topical and 
intralesional 
IFNa2b 
Inferior tarsal 
conjunctiva 
3  
  43 / M 26 Mucous discharge Topical and 
intralesional 
IFNa2b 
Superior forniceal 
conjunctiva and 
caruncle 
69 
  20 / M 13 None Topical and 
intralesional 
IFNa2b 
Superior Tarsal, 
bulbar and 
Forniceal 
9 
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Jakobiec 
(2016)28 
1 51 / M 27 Mass, poor 
prosthesis fit 
Excisional 
Biopsy 
Inferior Fornix 6  
Gaier (2017)3 1 51 / M 40 Mucopurulent 
discharge, poor 
prosthesis fit 
Exenteration, 
60Gy 30# XT 
Diffuse 6  
Current Study 
(2017) 
4 59 / M 30 Mass Exenteration Superior tarsal 36 
  65 / F 63 Mass, mucoid 
discharge 
Excisional 
biopsy, cryo, 
IFN 
Inferior tarsal 32 
  63 / M 42 Mass, poor 
prosthesis fit 
Exenteration Superior bulbar 12 
  73 / F 10 Mass Excisional 
biopsy, MMC 
Superior tarsal 6 
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Figure Legends 
Figure 1 (a to h):  
External photograph with conjunctival appearance for patient 1 to 4.  
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Figure 2 (A to H) : 
 
 
A. Case 1 Scanning power H&E image of the upper lid invasive conjunctival 
squamous cell carcinoma.  
B. Case 1-Higher power of A showing the invasive tumour. 
C. Case 1-Higher power of A showing the in-situ squamous carcinoma.  
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D. Case1-p16 immunohistochemistry (brown=positive) showing positivity in the in-
situ and invasive tumour (main figure). The top-right inset figure shows a higher 
power of the p16 staining, demonstrating nuclear and cytoplasmic staining.  
E Case 3 Scanning power H&E image of the upper lid showing papillary in-situ 
squamous cell carcinoma.  
F.Case 3-showing invasive squamous carcinoma infiltrating extraocular muscles 
(arrow).  
G. Case3-p16 immunohistochemistry showing positivity of the tumour (main figure). 
The top-right inset figure shows a higher power of the p16 staining, demonstrating 
nuclear and cytoplasmic staining.  
H-Case 4-showing in-situ squamous carcinoma with intra-lesional eosinophils, 
reflecting the patient’s atopic status. 
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